Altria Group, Inc. (MO) Stock Analysis
Is MO a good investment?
Altria Group, Inc. (MO) has a Plutrex AI rating of 42.0/100 as of October 10, 2026, indicating a Sell consensus. The stock is not classified as halal-compliant. Key strength: FCF of $8.303B annually funds $1.11/quarter dividend (4.7% raise confirmed) with strong coverage — 61+ consecutive years of dividend increases (Dividend King) at a ~6.2% current yield provides income floor for yield-seeking holders. Main concern: CRITICAL WORSENED OVERVALUATION: Stock at $71.68 is now 21.5% above the collapsed analyst consensus target of $59.00 (down from $68.50 fourteen days ago — a -13.9% target cut); PEG of 3.77 is a 24.9% premium to industry peers; DCF fair value $50–$58 implies 20–30% downside; no margin of safety exists for new buyers at current levels.
Investment Summary
Altria (MO) is a profitability-exceptional but structurally overvalued tobacco company trading at $71.68 — now 21.5% above the analyst consensus target of $59.00, which has collapsed from $68.50 just 14 days ago (a -$9.50 / -13.9% cut in the target). This target revision is the dominant new fact and forces a material downgrade. The core thesis remains unchanged: MO generates extraordinary FCF of $8.3B/year, operates at a 76.4% operating margin (+68% above the industry average of 45.4%), and has raised dividends for 61+ consecutive years — including a recent 4.7% increase from $1.06 to $1.11/quarter. However, against these strengths stands a PEG of 3.77 (24.9% premium to the industry's 3.02), forward EPS growth of only 3.55% (vs. industry 7.67%), revenue growth of 1.2% (vs. industry 6.5%), and now a stock price $12.68 above consensus. The headline 'MO Looks Cheap Until You See the Numbers: Negative Equity, Crumbling Margins' directly validates the fundamental overvaluation concern. At $71.68 with a $59 consensus target, the stock offers no margin of safety — it is a high-quality business at a poor price, with meaningful downside risk.
Key Strengths
- FCF of $8.303B annually funds $1.11/quarter dividend (4.7% raise confirmed) with strong coverage — 61+ consecutive years of dividend increases (Dividend King) at a ~6.2% current yield provides income floor for yield-seeking holders
- Operating margin of 76.4% is +68.2% above the tobacco industry average of 45.4%; gross margin 83.0% is +23.7% above peers — Marlboro's pricing power creates a structurally durable economic moat unmatched in the sector
- Trailing earnings decline of only -2.7% vs. industry average -11.1% shows MO is losing ground more slowly than peers on the most recent profitability measure, and on! PLUS reaching 120,000 stores suggests incremental smoke-free growth optionality
Key Concerns
- CRITICAL WORSENED OVERVALUATION: Stock at $71.68 is now 21.5% above the collapsed analyst consensus target of $59.00 (down from $68.50 fourteen days ago — a -13.9% target cut); PEG of 3.77 is a 24.9% premium to industry peers; DCF fair value $50–$58 implies 20–30% downside; no margin of safety exists for new buyers at current levels
- Structural secular decline with no acceleration: forward EPS growth 3.55% (1yr) and 4.0% (5yr) are ~50% below the industry average of 7.67%/7.68%; revenue growth 1.2% vs. industry 6.5%; the MO vs. PM comparison headline and 'crumbling margins' news article confirm the growth gap is not closing, and the price has moved further away from fair value, not closer
Plutrex 10-Factor AI Breakdown
Fundamental Analysis
Profitability is elite and unchanged: gross margin 83.0% (vs. industry 67.1%), operating margin 76.4% (vs. industry 45.4%), net margin 38.9% (vs. industry 27.9%), FCF $8.303B annually. These metrics support a Hold for existing income investors. Valuation, however, has deteriorated materially: P/E of 15.09x against 3.55% forward EPS growth yields a PEG of 3.77 — nearly 4x the '1.0 = fair value' threshold and 24.9% above the tobacco peer average PEG of 3.02. At $71.68 vs. analyst consensus of $59.00, implied downside is -17.7% in capital terms before any dividend credit. Using a DCF framework: $8.3B FCF, 10% discount rate, 3% terminal growth = fair value ~$50–$58, suggesting 20–30% overvaluation. Revenue growth of 1.2% YoY vs. industry 6.5% confirms MO is losing top-line ground at a rate 81.5% slower than peers. TTM earnings growth of -2.7% (better than industry's -11.1%) shows relative resilience but not improvement. Negative book equity (Debt/Equity N/A) reflects decades of buybacks and dividends exceeding retained earnings — leveraged but manageable given FCF coverage. The balance sheet carries real debt risk in a stress scenario. Growth score 12/100 and valuation score 20/100 are the anchors dragging the overall rating down.
News Sentiment
Altria Group is making headlines for all the right and wrong reasons this week — and for income investors, the picture is complicated. On the positive side, the cigarette giant just raised its quarterly dividend from $1.06 to $1.11 per share, a 4.7% increase that keeps Altria's legendary streak of 61+ consecutive annual dividend hikes alive, cementing its status as a 'Dividend King.' Analysts have spotlighted MO as a defensive income play, and retirement-focused investors are buzzing about strategies to generate $7,500 in annual passive income from tobacco stocks like Altria. The company's on! PLUS nicotine pouch brand just hit 120,000 retail stores, signaling real momentum in smoke-free alternatives. But not everyone is impressed. One pointed headline — 'MO Looks Cheap Until You See the Numbers: Negative Equity, Crumbling Margins' — cuts right to the heart of the bear case: the stock's attractive surface-level price masks deteriorating fundamentals, a leveraged balance sheet with negative book equity, and growth rates running at half the pace of tobacco peers. The comparison piece 'MO vs. PM: Which Tobacco Giant Has the Better Growth Story?' likely doesn't flatter Altria, given Philip Morris's far superior international and smoke-free product growth. For everyday investors, the message is this: Altria pays a great dividend, but at $71.68 — well above where analysts think it should trade — you're paying a premium price for a slowly shrinking business.
Risk Assessment
PRIMARY RISK: Analyst consensus target collapsed from $68.50 to $59.00 (-13.9%) in 14 days while the stock ROSE +4.2% to $71.68 — the gap between market price and analyst fair value is now $12.68 (21.5%), the widest it has been in this analysis series. Mean reversion toward the $59 target is the base case. SECONDARY RISK: PEG of 3.77 with only 4.0% five-year EPS growth means any multiple compression (e.g., rate normalization, tobacco regulation) accelerates downside. TERTIARY RISK: Negative book equity means MO has no asset cushion — in a credit stress event, the leveraged structure amplifies losses. MITIGATION: The $8.3B FCF and 6.2% dividend yield provide income compensation for holders. Dividend sustainability is not at risk near-term. For new buyers, the only appropriate action is to wait for a pullback toward $58–$62 where the yield approaches 7.2–7.7% and P/E drops to ~12.2–13.0x, providing genuine value compensation. Stop at $54.00 = 10% below $60 midpoint, appropriate given the volatility of a secular-decline tobacco name.
Related Halal Stocks
Related Stocks
Frequently Asked Questions
Is MO a halal stock?
No, Altria Group, Inc. (MO) is currently not classified as halal by AAOIFI criteria.
What is Plutrex's AI rating for MO?
Altria Group, Inc. (MO) has a Plutrex AI rating of 42.0/100 with a Sell consensus, based on a 10-factor analysis covering financial health, growth, valuation, profitability, debt, analyst sentiment, technical momentum, insider confidence, news sentiment, and halal compliance.
Is MO a good investment?
According to Plutrex AI, MO has a Sell rating (42.0/100). For the full analysis including trading plan and risk assessment, see the detailed breakdown above.
How can I invest in MO?
US stocks like MO can be bought through international brokers such as Interactive Brokers, accessible to Arab investors. Plutrex provides comprehensive analysis plus AI-generated trading plans with entry points, stop losses, and profit targets.
What are the main risks of investing in MO?
Plutrex AI identifies the main risks for MO by analyzing valuation, debt, market sentiment, and macro factors. See the Risk Assessment section above for the full breakdown.